COVID-19 Seroprevalence in Cirrhotic Patients and Effect of COVID-19 Infection on Liver Cirrhosis by Clinical Form in the Postinfectious Period

Various liver and/or biliary tract diseases due to vascular or circulatory problems have been reported, as well as inflammatory, infectious, autoimmunity, or drug-related liver diseases that may occur in relation to COVID-19 infection (2).Studies have reported that among COVID-19 patients, 2-11% have pre-existing and diagnosed liver disease, of which 0.3-2.4% are cases of liver cirrhosis (1,3).COVID-19 infection in patients with chronic liver disease may result in the development of serious clinical problems, such as acute insufficiency or decompensation of liver cirrhosis with a chronic background (2).Deficiencies in natural and acquired immunity in patients with cirrhosis increase the tendency to infections, and this is more evident in severe cases (4).